R. Derynck

Molecular Biology · 2001–2020

A researcher in the Science corpus: 16 papers; trusts 23 researchers and is trusted by 48 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 318 citations into it; #754 of 17,773 by trust here, #1,821 by citations
• Oncology — 207 citations into it; #163 of 1,698 by trust here, #431 by citations
• Cancer Research — 55 citations into it; #671 of 1,780 by trust here, #1,486 by citations
• Genetics — 45 citations into it
• Cell Biology — 43 citations into it
• Pathology and Forensic Medicine — 22 citations into it
• Immunology and Allergy — 20 citations into it

Whom R. Derynck trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. J. Massagué
2. Yigong Shi
3. Raghu Kalluri
4. R. Weinberg
5. Ying E. Zhang
6. C. Heldin
7. K. Miyazono
8. A. Moustakas
9. I. Stamenkovic
10. Se-Jin Lee

Who trusts R. Derynck overall

1. J. Massagué
2. Nikolaos G. Frangogiannis
3. B. Hinz
4. Wan-Wan Lin
5. Xin-Hua Feng
6. K. Flanders
7. M. Dobaczewski
8. O. De Wever
9. H. Lan
10. A. Moustakas

Papers from R. Derynck's perspective

Ordered by how strongly the researchers R. Derynck trusts endorse each paper. Same corpus, a different order for every researcher.

1. The epithelial-mesenchymal transition generates cells with properties of stem cells. (Cell)
2. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
3. Migrating cancer stem cells — an integrated concept of malignant tumour progression (Nature Reviews. Cancer)
4. Intravital imaging of cell movement in tumours (Nature Reviews. Cancer)
5. Tumor Metastasis: Molecular Insights and Evolving Paradigms (Cell)
6. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. (Genes & Development)
7. Metastasis: from dissemination to organ-specific colonization (Nature Reviews. Cancer)
8. Molecular definition of breast tumor heterogeneity. (Cancer Cell)
9. Smad-dependent and Smad-independent pathways in TGF-β family signalling (Nature)
10. Epithelial-mesenchymal transitions in development and disease. (Cell)

Their papers

• Smad-dependent and Smad-independent pathways in TGF-β family signalling (2003) — 4,396 citations
• SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS (2005) — 1,752 citations
• Molecular mechanisms of epithelial–mesenchymal transition (2014) — 7,497 citations
• TGF-β signaling in tumor suppression and cancer progression (2001) — 1,524 citations
• TGF-β-induced epithelial to mesenchymal transition (2009) — 2,369 citations
• TGF-β signaling in cancer – a double-edged sword (2001) — 667 citations
• TGF-&bgr; signaling and epithelial–mesenchymal transition in cancer progression (2013) — 782 citations
• TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA (2007) — 519 citations
• Guidelines and definitions for research on epithelial–mesenchymal transition (2020) — 1,774 citations
• TGF-β biology in cancer progression and tumor immunotherapy (2020) — 776 citations
• Specificity, versatility and control of TGF-β family signaling (2019) — 662 citations
• TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology. (2016) — 1,144 citations
• Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells (2011) — 620 citations
• Specificity and versatility in tgf-beta signaling through Smads. (2005) — 900 citations
• Smad-dependent and Smad-independent pathways in TGF-beta family signalling. (2003) — 2,776 citations
• TGF-beta signaling in tumor suppression and cancer progression. (2001) — 973 citations